Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän

Chronic limb-threatening … - Göteborgs universitet Till startsida
Till innehåll Läs mer om hur kakor används på gu.se

Chronic limb-threatening ischaemia - Prognosis after intervention

Författare Erik Baubeta Fridh
Datum för examination 2019-05-17
ISBN 978-91-7833-411-7
Förlag Göteborgs universitet
Publiceringsår 2019
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för radiologi
Språk en
Länkar hdl.handle.net/2077/60077
Ämnesord Amputation, arterial occlusive disease, atherosclerosis, magnetic resonance angiography, mortality, peripheral arterial disease, comorbidity
Ämneskategorier Radiologi


Introduction: Lower-extremity arterial disease (LEAD) is a major health problem worldwide. Chronic limb-threatening ischaemia (CLTI) is the most severe manifestation of LEAD. Open or endovascular recanalization is recommended for most patients with CLTI. The aim of this thesis has been to investigate the impact of comorbidities, medications, gender, preoperative symptoms, and revascularized arterial segment on outcome after revascularization in terms of amputation or death and to investigate whether it is possible to make a correct preoperative assessment of infrapopliteal lesions in CLTI patients using the TransAtlantic Inter-society Consensus (TASC) II classification on magnetic resonance angiography (MRA). Methods: All patients who were revascularized for intermittent claudication (IC, n = 6,272) and CLTI (n = 10,617) from May 2008 to May 2013 in Sweden were assembled in a database. Patients were identified using the Swedvasc register and the data was complemented with mandatory national healthcare registers. In addition, medical records of 1,366 patients were reviewed to safeguard accuracy on ipsilateral amputation. Descriptive statistics, Cox regression models with hazard ratios (HRs), and Kaplan-Meier curves were used in Papers I‒III. In Paper IV, 68 preoperative MRAs and perioperative digital subtraction angiographies (DSAs) were evaluated using the infrapopliteal TASC II criteria. Visual grading characteristics (VGC) analysis and Krippendorff’s α were used for analysis of differences and agreement between modalities and observers. Results: CLTI patients had different preoperative comorbidities than IC patients. The risk of amputation following revascularization for CLTI was particularly high during the first 6 months. Mortality was high in all revascularized LEAD patients. Renal insufficiency, diabetes, heart failure, atrial fibrillation, male gender and presence of tissue loss, were found to be independently associated with increased risk of amputation after revascularization for CLTI. Conversely, medication with low-dose acetylsalicylic acid and statins were associated with improved limb salvage and survival. No systematic difference was detected between MRA and DSA in grading of infrapopliteal lesions. Agreement between observers in preoperative assessment of infrapopliteal TASC II class was poor, mainly due to a variable choice of intended target vessel between observers. A suggested novel infrapopliteal aggregated lesion severity score (IALSS), based on evaluation of all four infrapopliteal arteries, had better inter-observer agreement. Conclusions: CLTI and IC affects different patient populations. Mortality is substantial in both. Amputation rate is particularly high in the first 6 months following revascularization for CLTI and associated with well-defined risk factors, most markedly renal insufficiency, diabetes, and tissue loss. Statins and platelet inhibitors should be considered for all patients with LEAD. Infrapopliteal TASC II grading can be done using MRA, but the required choice of a target vessel is a concern. An alternative score, independent of intended target vessel, may provide a more reproducible tool for assessment of infrapopliteal disease severity.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?